iShares US Pharmaceuticals ETF
IHE
IHE
143 hedge funds and large institutions have $379M invested in iShares US Pharmaceuticals ETF in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 50 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
146.55% less ownership
Funds ownership: 204.27% → 57.71% (-147%)
Holders
143
Holding in Top 10
1
Calls
$367K
Puts
–
Top Buyers
| 1 | +$7.36M | |
| 2 | +$4.98M | |
| 3 | +$3.08M | |
| 4 |
SCA
Southern Capital Advisors
Jackson,
Tennessee
|
+$2.64M |
| 5 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
+$2.01M |
Top Sellers
| 1 | -$51.9M | |
| 2 | -$11.7M | |
| 3 | -$8.4M | |
| 4 |
RIG
RiverFront Investment Group
Richmond,
Virginia
|
-$7.02M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$5.78M |